182 related articles for article (PubMed ID: 36405105)
1. Transjugular intrahepatic portosystemic shunt
Philipp M; Blattmann T; Bienert J; Fischer K; Hausberg L; Kröger JC; Heller T; Weber MA; Lamprecht G
World J Gastroenterol; 2022 Nov; 28(41):5944-5956. PubMed ID: 36405105
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.
Praktiknjo M; Clees C; Pigliacelli A; Fischer S; Jansen C; Lehmann J; Pohlmann A; Lattanzi B; Krabbe VK; Strassburg CP; Arroyo V; Merli M; Meyer C; Trebicka J
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00025. PubMed ID: 30939488
[TBL] [Abstract][Full Text] [Related]
3. Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score.
Chang J; Höfer P; Böhling N; Lingohr P; Manekeller S; Kalff JC; Dohmen J; Kaczmarek DJ; Jansen C; Meyer C; Strassburg CP; Trebicka J; Praktiknjo M
JHEP Rep; 2022 Mar; 4(3):100442. PubMed ID: 35198929
[TBL] [Abstract][Full Text] [Related]
4. History of Hepatic Encephalopathy Is Not a Contraindication to Transjugular Intrahepatic Portosystemic Shunt Placement for Refractory Ascites.
Saab S; Zhao M; Asokan I; Yum JJ; Lee EW
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00378. PubMed ID: 34333500
[TBL] [Abstract][Full Text] [Related]
5. Transjugular intrahepatic portosystemic shunt (TIPS) placement at index portal hypertensive decompensation (anticipant TIPS) in cirrhosis and the role of early intervention in variceal bleeding and ascites.
Rajesh S; Philips CA; Betgeri SS; George T; Ahamed R; Mohanan M; Augustine P
Indian J Gastroenterol; 2021 Aug; 40(4):361-372. PubMed ID: 34324168
[TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic shunt (TIPS) placement: A comparison of outcomes between patients with hepatic hydrothorax and patients with refractory ascites.
Young S; Bermudez J; Zhang L; Rostambeigi N; Golzarian J
Diagn Interv Imaging; 2019 May; 100(5):303-308. PubMed ID: 30522911
[TBL] [Abstract][Full Text] [Related]
7. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS.
Trebicka J; Gu W; Ibáñez-Samaniego L; Hernández-Gea V; Pitarch C; Garcia E; Procopet B; Giráldez Á; Amitrano L; Villanueva C; Thabut D; Silva-Junior G; Martinez J; Genescà J; Bureau C; Llop E; Laleman W; Palazon JM; Castellote J; Rodrigues S; Gluud L; Ferreira CN; Barcelo R; Cañete N; Rodríguez M; Ferlitsch A; Mundi JL; Gronbaek H; Hernández-Guerra M; Sassatelli R; Dell'Era A; Senzolo M; Abraldes JG; Romero-Gómez M; Zipprich A; Casas M; Masnou H; Primignani M; Weiss E; Catalina MV; Erasmus HP; Uschner FE; Schulz M; Brol MJ; Praktiknjo M; Chang J; Krag A; Nevens F; Calleja JL; Robic MA; Conejo I; Albillos A; Rudler M; Alvarado E; Guardascione MA; Tantau M; Bosch J; Torres F; Pavesi M; Garcia-Pagán JC; Jansen C; Bañares R;
J Hepatol; 2020 Nov; 73(5):1082-1091. PubMed ID: 32339602
[TBL] [Abstract][Full Text] [Related]
8. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
[TBL] [Abstract][Full Text] [Related]
9. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.
Strunk H; Marinova M
Rofo; 2018 Aug; 190(8):701-711. PubMed ID: 30045395
[TBL] [Abstract][Full Text] [Related]
10. Can pretransplant TIPS be harmful in liver transplantation? A propensity score matching analysis.
Matsushima H; Fujiki M; Sasaki K; Cywinski JB; D'Amico G; Uso TD; Aucejo F; David Kwon CH; Eghtesad B; Miller C; Quintini C; Hashimoto K
Surgery; 2020 Jul; 168(1):33-39. PubMed ID: 32268937
[TBL] [Abstract][Full Text] [Related]
11. Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites.
Stockhoff L; Schultalbers M; Tergast TL; Hinrichs JB; Gerbel S; Meine TC; Manns MP; Simon N; Cornberg M; Meyer BC; Maasoumy B
PLoS One; 2020; 15(6):e0235199. PubMed ID: 32584874
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
[TBL] [Abstract][Full Text] [Related]
13. Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt.
Yang C; Liu J; Shi Q; Huang S; Zhou C; Wang Y; Li T; Chen Y; Xiong B
J Gastroenterol Hepatol; 2021 Oct; 36(10):2893-2902. PubMed ID: 33973270
[TBL] [Abstract][Full Text] [Related]
14. The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions.
Deltenre P; Zanetto A; Saltini D; Moreno C; Schepis F
Hepatology; 2023 Feb; 77(2):640-658. PubMed ID: 35665949
[TBL] [Abstract][Full Text] [Related]
15. Transjugular Intrahepatic Portosystemic Shunt Benefits for Hepatic Sinusoidal Obstruction Syndrome Associated with Consumption of Gynura Segetum: a Propensity Score-Matched Analysis.
Li S; Li Y; Zhou C; Li H; Chen C; Peng C; Wang T; Liu F; Xiao J; Shi L
Cardiovasc Intervent Radiol; 2023 Jul; 46(7):931-942. PubMed ID: 37225971
[TBL] [Abstract][Full Text] [Related]
16. Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis.
Mukund A; Aravind A; Jindal A; Tevethia HV; Patidar Y; Sarin SK
Dig Dis Sci; 2024 Mar; 69(3):1025-1034. PubMed ID: 38341393
[TBL] [Abstract][Full Text] [Related]
17. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.
Dissegna D; Sponza M; Falleti E; Fabris C; Vit A; Angeli P; Piano S; Cussigh A; Cmet S; Toniutto P
Eur J Gastroenterol Hepatol; 2019 May; 31(5):626-632. PubMed ID: 30550458
[TBL] [Abstract][Full Text] [Related]
18. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
[TBL] [Abstract][Full Text] [Related]
19. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt.
Russo MW; Jacques PF; Mauro M; Odell P; Brown RS
Liver Transpl; 2002 Mar; 8(3):271-7. PubMed ID: 11910573
[TBL] [Abstract][Full Text] [Related]
20. The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites.
Garcia-Tsao G
Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):380-9. PubMed ID: 16819501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
